Cargando…
Targeted Therapy of Interleukin-34 as a Promising Approach to Overcome Cancer Therapy Resistance
SIMPLE SUMMARY: In the last decades, identification of the factors/mechanisms leading to cancer development has advanced the way clinicians combat this pathology. Indeed, the use of adjuvant chemotherapies and targeted therapies has markedly contributed to prolonging the survival of cancer patients....
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913481/ https://www.ncbi.nlm.nih.gov/pubmed/36765929 http://dx.doi.org/10.3390/cancers15030971 |